JPMorgan Chase & Co. Increases Position in SWK Holdings Co. (NASDAQ:SWKH)

JPMorgan Chase & Co. increased its position in shares of SWK Holdings Co. (NASDAQ:SWKH) by 224.4% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,108 shares of the company’s stock after purchasing an additional 4,225 shares during the quarter. JPMorgan Chase & Co.’s holdings in SWK were worth $106,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Barclays PLC boosted its position in SWK by 185.0% during the third quarter. Barclays PLC now owns 4,461 shares of the company’s stock worth $77,000 after acquiring an additional 2,896 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in SWK by 85.7% in the second quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company’s stock valued at $511,000 after purchasing an additional 13,892 shares during the last quarter. Finally, Victory Capital Management Inc. purchased a new position in SWK during the third quarter worth about $589,000. 99.27% of the stock is currently owned by hedge funds and other institutional investors.

SWK Stock Down 1.4 %

SWKH opened at $16.25 on Monday. The stock has a market capitalization of $198.74 million, a price-to-earnings ratio of 17.47 and a beta of 0.36. SWK Holdings Co. has a 12 month low of $15.14 and a 12 month high of $18.49. The company has a debt-to-equity ratio of 0.11, a current ratio of 5.06 and a quick ratio of 5.06. The business has a 50-day moving average of $16.20 and a two-hundred day moving average of $16.67.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.